Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
HD$353.35+19.79(+5.93%)Home Depot's Margin Outlook Faces Inflationary Headwinds2:36:13 PM ETANET$179.35+9.38(+5.52%)Own an AI or Tech ETF? Arista's Big Quarter Just Paid Off2:33:50 PM ETGOOG$289.61+11.32(+4.07%)Google Is Telling Schools to Take Its AI or Lose Its Search Engine2:32:16 PM ETGOOG$289.61+11.32(+4.07%)DuckDuckGo pitches itself to schools amid backlash over Google's AI policy2:29:52 PM ETKLAC$148.71-7.43(-4.76%)KLAC Q1 Earnings Call Highlights AI Demand and 2027 Growth Outlook2:25:32 PM ETPEP$142.46+5.21(+3.80%)Can PepsiCo's Snack Pricing Strategy Drive Volume Growth?2:25:31 PM ETSHOP$151.75+9.04(+6.33%)SHOP Q3 Earnings Beat Estimates, Revenues Rise on Strong GMV2:21:01 PM ETTSLA$389.30-9.04(-2.27%)Tesla Wants to Build 20,000 Optimus Robots a Week. Here's the Supplier That Gets Paid for Every Single One -- and It's Not Nvidia.2:20:00 PM ETMU$799.85-55.08(-6.44%)Micron Vs. SK hynix: Close The Pair, Keep The Better Floor2:09:33 PM ETSPCX$134.01-7.32(-5.18%)Should You Buy Anthropic's IPO on Day 1?2:09:00 PM ETMSFT$558.02+37.24(+7.15%)Microsoft: Don't Get Too Excited About Its Positive FCF (Rating Downgrade)2:05:25 PM ETNVDA$203.03-3.53(-1.71%)Why is Nvidia stock falling while broader markets rally on Democratic midterm win?2:03:27 PM ETMSFT$558.02+37.24(+7.15%)Microsoft Rallies as Political Risk Fades: What It Means for Your Retirement Fund2:03:00 PM ETBRK.A$865,775.80+29,645.51(+3.55%)Berkshire Hathaway Inc. Information Regarding Third Quarter Earnings Release2:00:00 PM ETAMZN$268.40+17.62(+7.03%)Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?1:51:45 PM ETDOW$32.35-1.44(-4.26%)November Dogs Of The Dow: No Buys, Yet 5 Are Worth Watching1:45:19 PM ETPANW$351.38+1.27(+0.36%)Palo Alto Networks, Inc. (PANW) Discusses Frontier AI Cybersecurity Threats, Defenses and Practical Response Prepared Remarks Transcript1:45:05 PM ETBLK$1,226.56+65.69(+5.66%)Michael Saylor Keeps Buying Bitcoin While ETF Investors Sell. Strategy Added 811 Coins While BlackRock's Bitcoin ETF Saw $405.3 Million Pulled Out In A Single Day1:43:22 PM ETMCD$280.55+17.48(+6.64%)McDonald's Corporation (MCD) Q3 2026 Earnings Call Transcript1:34:37 PM ETORCL$125.19-1.03(-0.82%)Oracle nixes $7B chip leasing deal with China's Tencent after Trump admin pushback: report1:34:26 PM ETTSLA$389.30-9.04(-2.27%)Was Elon Musk the Midterms' Biggest Loser? What It Means for Tesla and SpaceX Investors1:34:19 PM ETSMCI$29.68-1.76(-5.60%)Super Micro Has More Going for It Than Meets the Eye1:33:49 PM ETSMCI$29.68-1.76(-5.60%)Super Micro: Good News Doesn't Make A Difference Here1:31:37 PM ETCRM$226.43+4.25(+1.91%)Salesforce Stock Has Only Done This Twice Before. Here's What History Suggests Happens Next.1:30:00 PM ET

HRMY · NASDAQ

Harmony Biosciences Holdings, Inc.

$34.70 -2.34 (-6.32%)

Company overview

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company that develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX, is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$2B
Employees
268
Headquarters
Plymouth Meeting, PA
Website
harmonybiosciences.com
CEO
Jeffrey Dayno
Listed
August 19, 2020
P/E
13.76
Dividend yield
0.00%

Company financials

Revenue
$899M
Gross profit
$688M
Operating income
$190M
EBITDA
$233M
Net income
$146M
EPS
$2.52
Total assets
$1.3B
Total debt
$207M
Gross margin
76.55%
Net margin
16.20%
Earnings yield
7.27%

Revenue segmentation

By product (FY 2023)

No product segmentation.

By region (FY 2023)

Showing FY 2023

Price chart

28.2732.2236.1840.1344.08
HRMY 1D NASDAQ O37.97H38.75L36.33C37.02-0.89 (-2.35%)Vol1.45M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
HRMYHarmony Biosciences Holdings, Inc. Stock news Harmony Biosciences Q3 Earnings Call Highlights MarketBeat
HRMYHarmony Biosciences Holdings, Inc. Stock news Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Lag Estimates Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Press release Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile GlobeNewswire
HRMYHarmony Biosciences Holdings, Inc. Stock news Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Stock news HRMY or ARGX: Which Is the Better Value Stock Right Now? Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Stock news Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Stock news Revisiting Former Stock Picks Marriott, Logitech, Harmony Biosciences Barrons
HRMYHarmony Biosciences Holdings, Inc. Press release Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 GlobeNewswire
HRMYHarmony Biosciences Holdings, Inc. Stock news HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth? Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Stock news Why Harmony Biosciences Stock Got Mashed on Monday Fool - Investing News
HRMYHarmony Biosciences Holdings, Inc. Stock news Harmony Bio CEO Plans His Exit, And Shares Take An Unharmonious Hit Investors Business Daily
HRMYHarmony Biosciences Holdings, Inc. Press release Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth GlobeNewswire
HRMYHarmony Biosciences Holdings, Inc. Stock news HRMY vs. CSLLY: Which Stock Is the Better Value Option? Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Stock news Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Press release Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days GlobeNewswire
HRMYHarmony Biosciences Holdings, Inc. Stock news Insider Selling: Harmony Biosciences (NASDAQ:HRMY) Insider Sells $34,400.00 in Stock Defense World
HRMYHarmony Biosciences Holdings, Inc. Stock news Kumar Budur Sells 1,800 Shares of Harmony Biosciences (NASDAQ:HRMY) Stock Defense World
HRMYHarmony Biosciences Holdings, Inc. Stock news Sonoma Pharmaceuticals (NASDAQ:SNOA) & Harmony Biosciences (NASDAQ:HRMY) Critical Analysis Defense World
HRMYHarmony Biosciences Holdings, Inc. Stock news Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report? Zacks Investment Research
HRMYHarmony Biosciences Holdings, Inc. Press release Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress GlobeNewswire
See more
FAQ

Questions about Harmony Biosciences Holdings, Inc.

What does Harmony Biosciences Holdings, Inc. do?
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company that develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX, is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
What is HRMY's market cap?
Harmony Biosciences Holdings, Inc. (HRMY) is a listed stock with a live quote. The latest market cap on this page is $2B.
Where is Harmony Biosciences Holdings, Inc. headquartered?
Harmony Biosciences Holdings, Inc. is headquartered in Plymouth Meeting, PA.
How do I get HRMY news from the API?
Call GET /v1/news?tickers=HRMY. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does HRMY news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for HRMY, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the HRMY price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs